日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SNHG5 Exacerbates Sepsis-Induced Inflammatory Injury in Coronary Artery Endothelial Cells by Regulating METAP2-Mediated IL-8 Secretion.

SNHG5 通过调节 METAP2 介导的 IL-8 分泌加剧脓毒症引起的冠状动脉内皮细胞炎症损伤。

Exonic Variation in HLA-C, CFB, and TAP2 Associated With Increased Risk for Comorbid Crohn's Disease and Psoriasis

HLA-C、CFB 和 TAP2 的外显子变异与合并克罗恩病和银屑病的风险增加相关

Shaw, Vikram R; Byun, Jinyoung; Zhu, Catherine; Sninsky, Jared; Han, Younghun; Cohen, Jeffrey M; Amos, Christopher I

A Phase 1 Safety Study of Evexomostat (SDX-7320) in Patients with Late-Stage Cancer: An Antiangiogenic, Insulin-Sensitizing Drug Conjugate Targeting METAP2

一项针对晚期癌症患者的 Evexomostat (SDX-7320) 的 I 期安全性研究:一种靶向 METAP2 的抗血管生成、胰岛素增敏药物偶联物

Mita, Monica M; Mita, Alain C; Carver, Bradley J; Shanahan, James M; Mayes, Benjamin A; Dufour, Pierre J; Browning, David; Anderson-Villaluz, Alfred; Petersen, John S; Turnquist, David J; Cornelius, Peter

UTAP2: an enhanced user-friendly transcriptome and epigenome analysis pipeline

UTAP2:一种增强型、用户友好的转录组和表观基因组分析流程

Lindner, Jordana; Dassa, Bareket; Wigoda, Noa; Stelzer, Gil; Feldmesser, Ester; Prilusky, Jaime; Leshkowitz, Dena

Treponema pallidum inhibits CD4+ T-cell proliferation through METAP2: insights from Mendelian randomization analysis

梅毒螺旋体通过METAP2抑制CD4+ T细胞增殖:来自孟德尔随机化分析的启示

Liu, Zhaoping; Zhang, Xiaohong; Lin, Ting; Ding, Xuan; Yu, Han; Yao, Jiangchen; Gao, Ke; Wu, Yimou; Zhao, Feijun

STAP2 promotes the progression of renal fibrosis via HSP27.

STAP2 通过 HSP27 促进肾纤维化的进展

Yuan Yuan, Wei Xiao, Xiong Xi, Wang Xiong, Jiang Wei, Kuang Qihui, Zhu Kai, Chen Chen, Gan Jingzheng, Li Junjie, Yang Jun, Li Lili, Luo Pengcheng

Effects of KRTAP20-1 Gene Variation on Wool Traits in Chinese Tan Sheep

KRTAP20-1基因变异对中国褐羊羊毛性状的影响

Bai, Lingrong; Zhou, Huitong; Tao, Jinzhong; Hickford, Jon G H

Analysis of the c.1135G > A, c.1993A > G, c.2059T > C TAP2 gene variants and their relationship with latent tuberculosis infection in Mexico

对墨西哥TAP2基因c.1135G>A、c.1993A>G、c.2059T>C变异及其与潜伏性结核感染关系的研究

Cazarez-Navarro, Gerardo; Hernández-Cañaveral, Ivan; Colima-Fausto, Ana Gabriela; Palomares-Marín, Jaime; Licona-Lasteros, Karel; Pereira-Suarez, Ana Laura; Rodríguez-Preciado, Sergio Yair

Type I bare lymphocyte syndrome with novel TAP1 and TAP2 pathogenic variants

伴有新型TAP1和TAP2致病变异的I型裸淋巴细胞综合征

Samarkandy, Sahal; Khafaji, Randa; Alshareef, Alhusain

PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models

在临床前癌症模型中,PARP14抑制可恢复IFNγ驱动的获得性耐药后对PD-1免疫检查点抑制剂的反应。

Chun Wai Wong ,Christos Evangelou ,Kieran N Sefton # ,Rotem Leshem # ,Wei Zhang ,Vishaka Gopalan ,Sorayut Chattrakarn ,Macarena Lucia Fernandez Carro ,Erez Uzuner ,Holly Mole ,Daniel J Wilcock ,Michael P Smith ,Kleita Sergiou ,Brian A Telfer ,Dervla T Isaac ,Chang Liu ,Nicholas R Perl ,Kerrie Marie ,Paul Lorigan ,Kaye J Williams ,Patricia E Rao ,Raghavendar T Nagaraju ,Mario Niepel ,Adam F L Hurlstone